Literature DB >> 30013658

Role of the tumour protein P53 gene in human cervical squamous carcinoma cells: Discussing haematopoietic cell-specific protein 1-associated protein X-1-induced survival, migration and proliferation.

Bing Qian1, Li-Jun Zhao1, Fang Teng2, Ling-Juan Gao2, Rong Shen2.   

Abstract

The haematopoietic cell-specific protein 1-associated protein X-1 (HAX-1), as a mitochondrial membrane protein, induces cancer progression and metastasis. The present study aimed to investigate the role of HAX-1-induced survival, migration and proliferation of human cervical squamous carcinoma cells and to elucidate its potential molecular mechanisms. The level of HAX-1 was examined by quantitative polymerase chain reaction and western blot analyses. The survival, migration and proliferation of the human cervical squamous carcinoma SiHa cell line were measured by the water-soluble tetrazolium salt (WST-1) assay, Transwell assay and 3H-thymidine incorporation into DNA (3H-TdR) assay, respectively. The intracellular reactive oxygen species (ROS) was estimated by the fluorescence of H2DCFDA, and the mitochondrial membrane potential was tested using a JC-1 probe. The expression of the HAX-1 gene was significantly increased in human cervical carcinoma tissues relative to non-cancerous cervix tissues. Overexpression of HAX-1 increased the survival, migration and proliferation ability of SiHa cells, decreased the production of ROS, and maintained the integrity of the mitochondrial membrane and morphology. The effect brought on these cells could be abrogated by the addition of wild-type tumour protein P53 (p53) or carbonyl cyanide-p-trifluoro methoxyphenylhydrazone-induced mitochondrial dysfunction. In summary, these data support the notion that HAX-1 induced the survival, migration and proliferation of human cervical squamous carcinoma cells by inhibiting its downstream regulatory factor p53 in SiHa cells.

Entities:  

Keywords:  cervical cancer cells; haematopoietic cell-specific protein 1-associated protein X-1; mitochondrial function; tumour protein P53 gene

Year:  2018        PMID: 30013658      PMCID: PMC6036589          DOI: 10.3892/ol.2018.8886

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Structure-activity relationship of Triterpenes and derived Glycosides against cancer cells and mechanism of apoptosis induction.

Authors:  Shuo Shen; Wei Li; Ming-An Ouyang; Jian Wang
Journal:  Nat Prod Res       Date:  2017-06-29       Impact factor: 2.861

3.  Apremilast Induces Apoptosis of Human Colorectal Cancer Cells with Mutant KRAS.

Authors:  Kensuke Nishi; Hao Luo; Shuhei Ishikura; Keiko Doi; Yuri Iwaihara; Lauren Wills; George S Baillie; Toshifumi Sakata; Senji Shirasawa; Toshiyuki Tsunoda
Journal:  Anticancer Res       Date:  2017-07       Impact factor: 2.480

4.  Protease Omi cleaving Hax-1 protein contributes to OGD/R-induced mitochondrial damage in neuroblastoma N2a cells and cerebral injury in MCAO mice.

Authors:  Jia-yuan Wu; Mei Li; Li-juan Cao; Mei-ling Sun; Dong Chen; Hai-gang Ren; Qin Xia; Zhou-teng Tao; Zheng-hong Qin; Qing-song Hu; Guang-hui Wang
Journal:  Acta Pharmacol Sin       Date:  2015-08-24       Impact factor: 6.150

5.  HAX-1 promotes the chemoresistance, invasion, and tumorigenicity of esophageal squamous carcinoma cells.

Authors:  Sa-jia Sun; Long Feng; Guo-qiang Zhao; Zi-ming Dong
Journal:  Dig Dis Sci       Date:  2012-03-27       Impact factor: 3.199

6.  Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons.

Authors:  Jyh-Rong Chao; Evan Parganas; Kelli Boyd; Cheol Yi Hong; Joseph T Opferman; James N Ihle
Journal:  Nature       Date:  2008-02-20       Impact factor: 49.962

7.  Aspirin acetylates wild type and mutant p53 in colon cancer cells: identification of aspirin acetylated sites on recombinant p53.

Authors:  Guoqiang Ai; Rakesh Dachineni; D Ramesh Kumar; Srinivasan Marimuthu; Lloyd F Alfonso; G Jayarama Bhat
Journal:  Tumour Biol       Date:  2015-11-23

8.  Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer.

Authors:  Michael Frumovitz; Jennifer K Burzawa; Lauren A Byers; Yasmin A Lyons; Preetha Ramalingam; Robert L Coleman; Jubilee Brown
Journal:  Gynecol Oncol       Date:  2016-04-15       Impact factor: 5.482

9.  Bacterial Vaginosis and Cervical Intraepithelial Neoplasia: Is there an Association or is Co-Existence Incidental?

Authors:  Pushpa Sodhani; Sanjay Gupta; Ruchika Gupta; Ravi Mehrotra
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

10.  MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer.

Authors:  Ai-Hua Chen; Yu-E Qin; Wen-Fan Tang; Jing Tao; Hua-Mei Song; Manzhen Zuo
Journal:  Cancer Cell Int       Date:  2017-06-09       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.